Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lior Nesher

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|October 9, 2018
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsLynn El Haddad, Ella Ariza-Heredia, Dimpy P Shah, et al.
The Journal of Infectious Diseases|February 25, 2016
Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant RecipientsLior Nesher, Dimpy P Shah, Ella J Ariza-Heredia, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in IsraelTal Brosh-Nissimov, Efrat Orenbuch-Harroch, Michal Chowers, et al.
Science Advances|September 12, 2020
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriersNoam Shental, Shlomia Levy, Vered Wuvshet, et al.
Infection|November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort studyNofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Emerging Infectious Diseases|July 21, 2021
Spotted Fever Group Rickettsioses in Israel, 2010-2019Regev Cohen, Talya Finn, Frida Babushkin, et al.
Journal of Fungi (Basel, Switzerland)|July 27, 2022
Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort StudyMeital Elbaz, Maya Korem, Oshrat Ayalon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 20, 2022
Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort studyTal Brosh-Nissimov, Yasmin Maor, Meital Elbaz, et al.
Medicine|January 14, 2022
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center studyWaleed Kian, Melanie Zemel, Emily H Kestenbaum, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|October 9, 2018
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsLynn El Haddad, Ella Ariza-Heredia, Dimpy P Shah, et al.
The Journal of Infectious Diseases|February 25, 2016
Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant RecipientsLior Nesher, Dimpy P Shah, Ella J Ariza-Heredia, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2021
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in IsraelTal Brosh-Nissimov, Efrat Orenbuch-Harroch, Michal Chowers, et al.
Science Advances|September 12, 2020
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriersNoam Shental, Shlomia Levy, Vered Wuvshet, et al.
Infection|November 26, 2024
Shorter vs. standard-duration antibiotic therapy for nocardiosis: a multi-center retrospective cohort studyNofar Hezkelo Attias, Tal Schlaeffer-Yosef, Itay Zahavi, et al.
Emerging Infectious Diseases|July 21, 2021
Spotted Fever Group Rickettsioses in Israel, 2010-2019Regev Cohen, Talya Finn, Frida Babushkin, et al.
Journal of Fungi (Basel, Switzerland)|July 27, 2022
Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort StudyMeital Elbaz, Maya Korem, Oshrat Ayalon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 20, 2022
Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort studyTal Brosh-Nissimov, Yasmin Maor, Meital Elbaz, et al.
Medicine|January 14, 2022
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center studyWaleed Kian, Melanie Zemel, Emily H Kestenbaum, et al.
Pageof 8